News room
TP-102 Phase I/IIa clinical trial results published in Med by Cell Press
Technophage is excited to kick off the new year by sharing our latest publication in Med by Cell Press. Our Phase I/IIa study results for TP-102, an...
Technophage is looking for a Logistics/Supply chain Analyst to join the team
Technophage is currently looking for a Logistics/Supply chain Analyst to join our Quality and Manufacturing team. Technophage requires a degre in...
New INFARMED guidance on the use of phage therapy in the hospital context
Technophage congratulates INFARMED, I.P. on the approval of phage therapy in Portugal, a groundbreaking achievement celebrated alongside the release...
Celebrating Success and Building Bridges: Our 2024 End-of-Year Event
This year, we combined our traditional annual team-building with a festive Christmas celebration, bringing together all our collaborators for a...
Technophage was recognized with ‘PME líder 2024’ distinction by IAPMEI
We are thrilled to announce that Technophage has once again been recognized by IAPMEI, I.P. – Agência para a Competitividade e Inovação (Agency for...